Multivariate Analysis of the Predictors of Survival for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Focusing on Superselective Chemoembolization.
- Author:
Suk Kyeong JI
1
;
Yun Ku CHO
;
Yong Sik AHN
;
Mi Young KIM
;
Yoon Ok PARK
;
Jae Kyun KIM
;
Wan Tae KIM
Author Information
- Publication Type:Original Article
- Keywords: Hepatocellular carcinoma; Survival; Therapy; Chemoembolization
- MeSH: Adult; Aged; Antibiotics, Antineoplastic/administration & dosage; Carcinoma, Hepatocellular/mortality/*therapy; *Chemoembolization, Therapeutic; Contrast Media/administration & dosage; Disease-Free Survival; Doxorubicin/administration & dosage; Female; Humans; Iodized Oil/administration & dosage; Liver Neoplasms/mortality/*therapy; Male; Middle Aged; Prognosis
- From:Korean Journal of Radiology 2008;9(6):534-540
- CountryRepublic of Korea
- Language:English
- Abstract: OBJECTIVE: While the prognostic factors of survival for patients with hepatocellular carcinoma (HCC) who underwent transarterial chemoembolization (TACE) are well known, the clinical significance of performing selective TACE for HCC patients has not been clearly documented. We tried to analyze the potential factors of disease-free survival for these patients, including the performance of selective TACE. MATERIALS AND METHODS: A total of 151 patients with HCC who underwent TACE were retrospectively analyzed for their disease-free survival (a median follow-up of 23 months, range: 1-88 months). Univariate and multivariate analyses were performed for 20 potential factors by using the Cox proportional hazard model, including 19 baseline factors and one procedure-related factor (conventional versus selective TACE). The parameters that proved to be significant on the univariate analysis were subsequently tested with the multivariate model. RESULTS: Conventional or selective TACE was performed for 40 and 111 patients, respectively. Univariate and multivariate analyses revealed that tumor multiplicity, venous tumor thrombosis and selective TACE were the only three independent significant prognostic factors of disease-free survival (p = 0.002, 0.015 and 0.019, respectively). CONCLUSION: In our study, selective TACE was a favorable prognostic factor for the disease-free survival of patients with HCC who underwent TACE.
